- Q1 2024 Emergent BioSolutions Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Emergent BioSolutions Inc Earnings Call TranscriptMar 06, 2024€3.04 (-3.55%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2023€2.22 (+2.58%)Earnings
- Q2 2023 Emergent BioSolutions Inc Earnings Call TranscriptAug 08, 2023€6.66 (+0.60%)Earnings
- Q1 2023 Emergent BioSolutions Inc Earnings Call TranscriptMay 09, 2023€8.26 (+2.48%)Earnings
- Q4 2022 Emergent BioSolutions Inc Earnings Call TranscriptFeb 27, 2023€12.94 (-3.53%)Earnings
- Q3 2022 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2022€20.18 (+0.96%)Earnings
- Q2 2022 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2022€33.67 (-4.70%)Earnings
- Emergent BioSolutions Inc at Goldman Sachs Leveraged Finance and Credit Conference TranscriptMay 12, 2022
- Emergent BioSolutions Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Emergent BioSolutions Inc Earnings Call TranscriptApr 28, 2022€34.68 (-0.43%)Earnings
- Emergent BioSolutions Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Q4 2021 Emergent BioSolutions Inc Earnings Call TranscriptFeb 24, 2022€36.49 (-3.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Emergent BioSolutions Inc Earnings Call TranscriptNov 04, 2021€45.25 (+3.38%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Emergent BioSolutions Inc Earnings Call TranscriptJul 29, 2021€54.82 (+4.30%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Emergent BioSolutions Inc Earnings Call TranscriptApr 29, 2021€50.48 (-4.07%)Earnings
- Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Emergent BioSolutions Inc Earnings Call TranscriptFeb 18, 2021€101Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Emergent BioSolutions Inc Earnings Call TranscriptNov 05, 2020€84 (+5.66%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Emergent BioSolutions Inc Earnings Call TranscriptJul 30, 2020€80 (+2.56%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Emergent BioSolutions Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Emergent BioSolutions Inc Earnings Call TranscriptApr 30, 2020€68.5 (+0.74%)Earnings
- Q4 2019 Emergent BioSolutions Inc Earnings Call TranscriptFeb 20, 2020€59.5 (+0.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Emergent BioSolutions Inc Analyst and Investor Day TranscriptNov 21, 2019
- Q3 2019 Emergent BioSolutions Inc Earnings Call TranscriptNov 06, 2019€52 (+2.97%)Earnings
- Q2 2019 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2019€39.65 (-0.92%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 23, 2019
- Q1 2019 Emergent BioSolutions Inc Earnings Call TranscriptMay 02, 2019€46.51 (-2.15%)Earnings
- Q4 2018 Emergent BioSolutions Inc Earnings Call TranscriptFeb 21, 2019€57.45 (-0.95%)Earnings
Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm one of the Biotech Analysts at JPMorgan. And we're continuing the 2020 healthcare conference with Emergent BioSolutions. We're going to do a Q&A session with the management team right after this. It's just down the hall in the Yorkshire room. But for the presentation, I'm going to turn it over to the company's President and CEO, Bob Kramer.
Thanks, Jess. Good morning, everybody. A special thank you to JPMorgan as well as to Jess who have supported our company for a long time, first going public in 2006, and I've appreciated and enjoyed Jess' coverages for the last several years.
So this morning, I'm going to do a couple of things. I'm going to go through an overview of Emergent BioSolutions, who we are as a company, what we focus on, and hopefully give you a better appreciation for what differentiates us from most other companies that you'll
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)